Neutrophils and Vascular Endothelial Permeability

中性粒细胞和血管内皮通透性

基本信息

  • 批准号:
    7151206
  • 负责人:
  • 金额:
    $ 25.55万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1999
  • 资助国家:
    美国
  • 起止时间:
    1999-04-01 至 2008-11-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): During episodes of inflammation and hypoxia, vascular endothelial cells interact with polymorphonuclear leukocytes (PMN, neutrophils) in both direct and indirect ways. Under such conditions, PMN may significantly modulate endothelial function, including vascular barrier function. Our previous studies explored the possibility that activated PMN may liberate factors which promote endothelial barrier function, and as such, may serve as a counter-regulatory pathway for potentially detrimental factors liberated at such sites. These studies identified a number of previously unappreciated molecules important in endothelial permeability, including soluble mediators (e.g. 5'AMP, glutamate), membrane proteins (CD73, metabotropic glutamate receptors, alpha-v beta-3), and cytoskeletal crosslinking proteins [e.g. vasodilator-stimulated phosphoprotein (VASP)] in maintenance of junctional permeability during interactions with PMN. In this proposal, we will test the hypothesis that PMN-derived factors regulate endothelial permeability. As such, three specific aims are proposed to test this hypothesis. First, we will elucidate the molecular pathway(s) ecto-nucleotidase regulation of endothelial permeability. We will utilize extensive in vitro and in vivo models to answer basic questions regarding the cause and effect relationship between ecto-nucleotidase expression and vascular barrier function. Second, we will explore the molecular mechanisms of vascular barrier regulation by exogenous glutamate. As such, we will elucidate the cooperative contributions of endothelial glutamate receptors with VASP in vitro and in vivo. Third, we will determine the relationship between PMN-derived extracellular mediators with endothelial cell-cell junction coupling. In particular, we will concentrate efforts on understanding VASP interactions with endothelial tight junctions and the influence of glutamate and adenine nucleotides on junctional reorganization in real- time. The overall aim of this proposal is to elucidate the molecular pathways critical to vascular barrier regulation in hypoxia and during inflammation.
描述(由申请方提供):在炎症和缺氧发作期间,血管内皮细胞以直接和间接方式与多形核白细胞(PMN,中性粒细胞)相互作用。在这种情况下,PMN可以显著调节内皮功能,包括血管屏障功能。我们以前的研究探讨了激活的中性粒细胞可能释放促进内皮屏障功能的因子的可能性,因此,可能作为在这些网站释放的潜在有害因子的反调节途径。这些研究确定了许多以前未被认识到的在内皮通透性中重要的分子,包括可溶性介质(例如5 'AMP、谷氨酸)、膜蛋白(CD 73、代谢型谷氨酸受体、α-v β-3)和细胞骨架交联蛋白[例如血管舒张剂刺激的磷蛋白(VASP)],它们在与PMN相互作用期间维持连接通透性。在这个建议中,我们将测试的假设,中性粒细胞衍生的因子调节内皮通透性。因此,提出了三个具体目标来检验这一假设。首先,我们将阐明外核苷酸酶调节内皮通透性的分子途径。我们将利用广泛的体外和体内模型来回答有关外核苷酸酶表达和血管屏障功能之间的因果关系的基本问题。其次,我们将探讨外源性谷氨酸调节血管屏障的分子机制。因此,我们将阐明合作的贡献,血管内皮细胞谷氨酸受体与VASP在体外和体内。第三,我们将确定中性粒细胞衍生的细胞外介质与内皮细胞-细胞连接偶联之间的关系。特别是,我们将集中精力了解VASP与内皮紧密连接的相互作用,以及谷氨酸和腺嘌呤核苷酸对真实的连接重组的影响。该提案的总体目标是阐明缺氧和炎症过程中对血管屏障调节至关重要的分子途径。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Sean P Colgan其他文献

Sean P Colgan的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Sean P Colgan', 18)}}的其他基金

Gut microbiome effects on intestinal barrier function and metabolic syndrome in HIV positive men who have sex with men
肠道微生物群对男男性行为艾滋病毒阳性男性肠道屏障功能和代谢综合征的影响
  • 批准号:
    10674923
  • 财政年份:
    2022
  • 资助金额:
    $ 25.55万
  • 项目类别:
Gut microbiome effects on intestinal barrier function and metabolic syndrome in HIV positive men who have sex with men
肠道微生物群对男男性行为艾滋病毒阳性男性肠道屏障功能和代谢综合征的影响
  • 批准号:
    10527542
  • 财政年份:
    2022
  • 资助金额:
    $ 25.55万
  • 项目类别:
Metabolic Regulation of Inflammation by Microbial-Derived Short Chain Fatty Acids
微生物衍生的短链脂肪酸对炎症的代谢调节
  • 批准号:
    9897168
  • 财政年份:
    2015
  • 资助金额:
    $ 25.55万
  • 项目类别:
METABOLIC REGULATION OF INFLAMMATION BY MICROBIAL-DERIVED SHORT CHAIN FATTY ACIDS
微生物衍生的短链脂肪酸对炎症的代谢调节
  • 批准号:
    9242634
  • 财政年份:
    2015
  • 资助金额:
    $ 25.55万
  • 项目类别:
METABOLIC CONTROL OF EPITHELIAL AUTOPHAGY DURING INFLAMMATION
炎症过程中上皮自噬的代谢控制
  • 批准号:
    9274257
  • 财政年份:
    2015
  • 资助金额:
    $ 25.55万
  • 项目类别:
Metabolic Regulation of Inflammation by Microbial-Derived Short Chain Fatty Acids
微生物衍生的短链脂肪酸对炎症的代谢调节
  • 批准号:
    10375388
  • 财政年份:
    2015
  • 资助金额:
    $ 25.55万
  • 项目类别:
METABOLIC CONTROL OF EPITHELIAL AUTOPHAGY DURING INFLAMMATION
炎症过程中上皮自噬的代谢控制
  • 批准号:
    9066687
  • 财政年份:
    2015
  • 资助金额:
    $ 25.55万
  • 项目类别:
Metabolic Regulation of Inflammation by Microbial-Derived Short Chain Fatty Acids
微生物衍生的短链脂肪酸对炎症的代谢调节
  • 批准号:
    10601042
  • 财政年份:
    2015
  • 资助金额:
    $ 25.55万
  • 项目类别:
METABOLIC REGULATION OF INFLAMMATION BY MICROBIAL-DERIVED SHORT CHAIN FATTY ACIDS
微生物衍生的短链脂肪酸对炎症的代谢调节
  • 批准号:
    9027837
  • 财政年份:
    2015
  • 资助金额:
    $ 25.55万
  • 项目类别:
Metabolic Regulation of Mucosal Inflammation
粘膜炎症的代谢调节
  • 批准号:
    9339524
  • 财政年份:
    2014
  • 资助金额:
    $ 25.55万
  • 项目类别:

相似海外基金

Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
  • 批准号:
    MR/X02329X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 25.55万
  • 项目类别:
    Fellowship
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
  • 批准号:
    MR/Y009568/1
  • 财政年份:
    2024
  • 资助金额:
    $ 25.55万
  • 项目类别:
    Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
  • 批准号:
    10090332
  • 财政年份:
    2024
  • 资助金额:
    $ 25.55万
  • 项目类别:
    Collaborative R&D
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
  • 批准号:
    MR/X021882/1
  • 财政年份:
    2024
  • 资助金额:
    $ 25.55万
  • 项目类别:
    Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
  • 批准号:
    MR/X029557/1
  • 财政年份:
    2024
  • 资助金额:
    $ 25.55万
  • 项目类别:
    Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
  • 批准号:
    EP/Y003527/1
  • 财政年份:
    2024
  • 资助金额:
    $ 25.55万
  • 项目类别:
    Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
  • 批准号:
    EP/Y030338/1
  • 财政年份:
    2024
  • 资助金额:
    $ 25.55万
  • 项目类别:
    Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
  • 批准号:
    2312694
  • 财政年份:
    2024
  • 资助金额:
    $ 25.55万
  • 项目类别:
    Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
  • 批准号:
    24K19395
  • 财政年份:
    2024
  • 资助金额:
    $ 25.55万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Collaborative Research: Changes and Impact of Right Ventricle Viscoelasticity Under Acute Stress and Chronic Pulmonary Hypertension
合作研究:急性应激和慢性肺动脉高压下右心室粘弹性的变化和影响
  • 批准号:
    2244994
  • 财政年份:
    2023
  • 资助金额:
    $ 25.55万
  • 项目类别:
    Standard Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了